Ascendis Health Limited (ASC.JO)
ZAc 78.0
(0.0%)
ZAc 78.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 528.13 Million ZAR | -12.64% |
| 2022 | 604.53 Million ZAR | -5.21% |
| 2021 | 637.73 Million ZAR | -31.48% |
| 2020 | 930.67 Million ZAR | -71.02% |
| 2019 | 3.21 Billion ZAR | 34.42% |
| 2018 | 2.38 Billion ZAR | -31.14% |
| 2017 | 3.46 Billion ZAR | 23.34% |
| 2016 | 2.81 Billion ZAR | 80.06% |
| 2015 | 1.56 Billion ZAR | 27.17% |
| 2014 | 1.22 Billion ZAR | 68.79% |
| 2013 | 727.84 Million ZAR | 182.65% |
| 2012 | 257.5 Million ZAR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 FY | 528.13 Million ZAR | -12.64% |
| 2023 Q4 | 282.72 Million ZAR | 99.62% |
| 2023 Q1 | 150.95 Million ZAR | -40.07% |
| 2023 Q3 | 141.63 Million ZAR | -42.29% |
| 2023 Q2 | 245.41 Million ZAR | 62.57% |
| 2022 Q4 | 251.9 Million ZAR | 46.29% |
| 2022 FY | 604.53 Million ZAR | -5.21% |
| 2022 Q3 | 172.19 Million ZAR | -37.66% |
| 2022 Q2 | 276.22 Million ZAR | 77.12% |
| 2022 Q1 | 155.94 Million ZAR | -66.07% |
| 2021 Q4 | 459.62 Million ZAR | 179.47% |
| 2021 Q2 | 104.59 Million ZAR | -38.68% |
| 2021 FY | 637.73 Million ZAR | -31.48% |
| 2021 Q1 | 170.56 Million ZAR | -43.89% |
| 2021 Q3 | 164.46 Million ZAR | 57.23% |
| 2020 Q3 | 304 Million ZAR | -81.62% |
| 2020 Q4 | 304 Million ZAR | 0.0% |
| 2020 Q1 | 75.56 Million ZAR | -94.17% |
| 2020 Q2 | 1.65 Billion ZAR | 2088.3% |
| 2020 FY | 930.67 Million ZAR | -71.02% |
| 2019 Q3 | -535.84 Million ZAR | -134.94% |
| 2019 FY | 3.21 Billion ZAR | 34.42% |
| 2019 Q1 | 687.29 Million ZAR | 23.08% |
| 2019 Q2 | 1.53 Billion ZAR | 123.15% |
| 2019 Q4 | 1.29 Billion ZAR | 341.96% |
| 2018 FY | 2.38 Billion ZAR | -31.14% |
| 2018 Q4 | 558.39 Million ZAR | 7.97% |
| 2018 Q3 | 517.17 Million ZAR | -67.88% |
| 2018 Q2 | 1.61 Billion ZAR | 105.42% |
| 2018 Q1 | 783.76 Million ZAR | 73.84% |
| 2017 Q4 | 450.86 Million ZAR | 0.0% |
| 2017 FY | 3.46 Billion ZAR | 23.34% |
| 2017 Q1 | 815.36 Million ZAR | 0.0% |
| 2017 Q2 | 815.36 Million ZAR | 0.0% |
| 2017 Q3 | 450.86 Million ZAR | -44.7% |
| 2016 Q1 | 661.89 Million ZAR | 76.71% |
| 2016 Q2 | 661.89 Million ZAR | 0.0% |
| 2016 FY | 2.81 Billion ZAR | 80.06% |
| 2015 Q4 | 374.56 Million ZAR | -0.02% |
| 2015 Q2 | 406.93 Million ZAR | 0.0% |
| 2015 Q3 | 374.64 Million ZAR | -7.94% |
| 2015 Q1 | 406.93 Million ZAR | 29.0% |
| 2015 FY | 1.56 Billion ZAR | 27.17% |
| 2014 Q3 | 315.44 Million ZAR | 5.57% |
| 2014 Q2 | 298.81 Million ZAR | 0.0% |
| 2014 Q1 | 298.81 Million ZAR | 0.0% |
| 2014 Q4 | 315.44 Million ZAR | 0.0% |
| 2014 FY | 1.22 Billion ZAR | 68.79% |
| 2013 Q1 | 152.55 Million ZAR | 0.0% |
| 2013 FY | 727.84 Million ZAR | 182.65% |
| 2013 Q2 | 152.55 Million ZAR | 0.0% |
| 2012 Q1 | 64.9 Million ZAR | 0.0% |
| 2012 Q2 | 64.9 Million ZAR | 0.0% |
| 2012 FY | 257.5 Million ZAR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|